Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

Table 2 DLS diameter values in number and intensity modes as well as percentage intensity of ozonated whole blood oxy-Hb of the non-diabetic individual and four diabetic patients

Samples	Ozone concentrations	Diameter (nm) (number mode)	Diameter (nm) (intensity mode)	Intensity % (intensity mode)
Oxy-Hb Non-diabetic individual A	Non-ozonated	5.73	6.23 155 567	18.1 62.7 16
	15 μg/ml	6.10	6.60 112 365	58.3 13.8 27.9
	35 μg/ml	5.73	6.71 166 956	59.6 25.5 13.4
	55 μg/ml	6.07	6.60 129 469	64.1 18.2 17.6
Oxy-Hb Diabetic patient B	Non-ozonated	5.98	6.54 62.5 262	55.2 3 41.8
	15 μg/ml	6.17	6.54 183	41.4 58.6
	35 μg/ml	6.66	6.75 74.5 480	30.4 6.4 63.2
	55 μg/ml	6.04	6.34 168	56.1 43.9
Oxy-Hb Diabetic patient C	Non-ozonated	7.80	26.1 262 4260	85.4 12.3 2.4
	15 μg/ml	15.3	31 271 4470	68.1 24.6 7.3
	35 μg/ml	10.8	25.9 791 3610	88.5 6.5 5
	55 μg/ml	11.5	25 459 4270	89.4 5.7 4.9
Oxy-Hb Diabetic patient D	Non-ozonated	5.8	8.83 317 5100	52.2 29 18.9
	15 μg/ml	5.97	7.87 201 3180	40.7 17.3 41.9
	35 μg/ml	5.30	7.34 289 4740	30.2 25.6 44.1
	55 μg/ml	5.90	7.27 172 1340 Fourth peak not calculated	32.2 14.3 41.4 Fourth peak not calculated
Oxy-Hb Diabetic patient E	Non-ozonated	7.04	7.22 253	44.0 56.0
	15 μg/ml	7.53	7.93 234	48.5 51.5
	35 μg/ml	7.87	8.06 219	45.5 54.5
	55 μg/ml	6.41	7.11 72.3 341	56.4 5.5 38.2

ISSN: 1479-5876